Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LEO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
VTI1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEMIN7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DBI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF593 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPECC1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEF1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS18B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WBSCR22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLVRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLXIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on